Hosted on MSN7mon
FDA Expands AstraZeneca's (AZN) Imfinzi Label in Lung CancerImage Source: Zacks Investment Research Imfinzi is a key revenue driver ... filing seeking label expansion for Imfinzi in patients with limited-stage small cell lung cancer (LS-SCLC) whose disease ...
Hosted on MSN12mon
Merck to test lung cancer combo therapy in late-stage trialMerck (NYSE:MRK) has initiated a late-stage trial to test its experimental ... patients with metastatic non-small cell lung cancer (NSCLC). The Phase 3 clinical trial (NCT06345729) will compare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback